AU2022342245A1 - Drug conjugates of sugar derivatives and uses thereof as senolytic agents - Google Patents

Drug conjugates of sugar derivatives and uses thereof as senolytic agents Download PDF

Info

Publication number
AU2022342245A1
AU2022342245A1 AU2022342245A AU2022342245A AU2022342245A1 AU 2022342245 A1 AU2022342245 A1 AU 2022342245A1 AU 2022342245 A AU2022342245 A AU 2022342245A AU 2022342245 A AU2022342245 A AU 2022342245A AU 2022342245 A1 AU2022342245 A1 AU 2022342245A1
Authority
AU
Australia
Prior art keywords
compound
disease
diseases
methyl
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022342245A
Other languages
English (en)
Inventor
Gus BERGNES
Mark A. Gallop
Jeffrey R. JASPER
Paul Keitz
Marco Quarta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rubedo Life Sciences Inc
Original Assignee
Rubedo Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rubedo Life Sciences Inc filed Critical Rubedo Life Sciences Inc
Publication of AU2022342245A1 publication Critical patent/AU2022342245A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2022342245A 2021-09-13 2022-09-13 Drug conjugates of sugar derivatives and uses thereof as senolytic agents Pending AU2022342245A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163243539P 2021-09-13 2021-09-13
US63/243,539 2021-09-13
PCT/US2022/076360 WO2023039600A1 (en) 2021-09-13 2022-09-13 Drug conjugates of sugar derivatives and uses thereof as senolytic agents

Publications (1)

Publication Number Publication Date
AU2022342245A1 true AU2022342245A1 (en) 2024-03-28

Family

ID=85507744

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022342245A Pending AU2022342245A1 (en) 2021-09-13 2022-09-13 Drug conjugates of sugar derivatives and uses thereof as senolytic agents

Country Status (7)

Country Link
US (3) US20230137021A1 (cg-RX-API-DMAC10.html)
EP (1) EP4380575A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024533426A (cg-RX-API-DMAC10.html)
CN (1) CN118475356A (cg-RX-API-DMAC10.html)
AU (1) AU2022342245A1 (cg-RX-API-DMAC10.html)
CA (1) CA3232213A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023039600A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11897915B2 (en) * 2021-09-13 2024-02-13 Rubedo Life Sciences, Inc. Sugar derivatives and uses thereof to prepare novel senolytic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2890981T3 (en) * 2012-08-28 2019-03-04 Univ Tuebingen Medizinische Fakultaet Senescence tracers
US9993472B2 (en) * 2014-01-28 2018-06-12 Unity Biotechnology, Inc. Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
JP7419347B2 (ja) * 2018-04-23 2024-01-22 エイジェックス・セラピューティクス・インコーポレイテッド 哺乳動物細胞における組織再生の誘導及びセノリシスのための改良された方法
MX2021000395A (es) * 2018-07-11 2021-05-12 Rubedo Life Sciences Inc Composiciones senolíticas y usos de las mismas.

Also Published As

Publication number Publication date
US20240299555A1 (en) 2024-09-12
EP4380575A1 (en) 2024-06-12
WO2023039600A1 (en) 2023-03-16
CN118475356A (zh) 2024-08-09
US20230137021A1 (en) 2023-05-04
US20250222115A1 (en) 2025-07-10
JP2024533426A (ja) 2024-09-12
CA3232213A1 (en) 2023-03-16
EP4380575A4 (en) 2025-07-23

Similar Documents

Publication Publication Date Title
KR102843318B1 (ko) 세놀리틱 조성물 및 이의 사용
EP3833670B1 (en) 6-(4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3h)-one derivatives and related compounds as ptpn11 (shp2) inhibitors for treating cancer
JP7601788B2 (ja) チロシンキナーゼの複素環式阻害剤
US20250222115A1 (en) Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents
US20260007689A1 (en) GPX4 Inhibitors and Senolytic Compounds and Uses Thereof
CA3105982C (en) Senolytic compositions and uses thereof
US20250171435A1 (en) Carbon Linked BCL Inhibitors and Senolytic Compounds and Uses Thereof
WO2025199126A1 (en) Gpx4 inhibitors and senolytic compounds and uses thereof
WO2025117556A1 (en) Phosphorous containing bcl inhibitors and senolytic compounds and uses thereof